ROR1: A Promising Target in B-NHL (MCL, CLL, MZL, DLBCL) Clinical Experience with A Fully-Humanized mAb and Novel Car T-Cell Therapy (Michael Choi, James Breitmeyer, Hun Lee, P. Connor Johnson, Tanya Siddiqi, Joanna Rhodes, William Wierda, Iris Isufi, Joseph Tuscano, Lori Leslie, Jacqueline Barrientos, Salim Yazji, Yisrael Katz, James Robinson, Angela Pietrofeso, Susan O’Neill, Matthew Mei, Caron Jacobson, Thomas J Kipps, Michael Wang, DAVA Oncology  – 2024 Whistler Global Summit on Hematologic Malignancies)